Imagine folding a piece of paper like origami to create a tiny, 3D house for human cells to live in. Instead of using expensive plastics and complex machinery, this method uses paper to mimic how organs work and includes built-in sensors to watch the cells in real-time. It's like replacing a high-end laboratory setup with a smart, biodegradable paper kit that does the same job.
Traditional Organ-on-a-Chip devices are too expensive and complex to manufacture, limiting their use in large-scale drug screening and in regions with limited resources.
A paper-based microfluidic device using origami folding and anisotropic cryogels to mimic human organ tissues and integrate electrochemical sensors.
If you are a drug discovery firm dealing with high costs of early-stage drug screening — this project developed paper-based OoC devices that provide a more affordable and sustainable way to perform pharmacological studies. This allows for faster, cheaper testing of how drugs affect human tissues.
If you are a device manufacturer dealing with the lack of accessible diagnostic tools in resource-limited settings — this project developed origami-inspired paper devices that are eco-friendly and widely accessible. These can be used for on-site monitoring of cellular responses to stimuli.
If you are a startup dealing with the difficulty of creating 3D environments for cell co-cultures — this project developed anisotropic cryogels that mimic native deep cartilage layers. This provides a scalable way to create biomimetic scaffolds for tissue engineering.
Based on available project data, it replaces expensive materials and complex fabrication processes with paper, which is inherently more affordable and accessible.
The project mentions a scalable framework for creating biomimetic scaffolds and the use of paper as a primary material, which suggests high scalability potential.
Based on available project data, there is no specific mention of patents or licensing terms; the project is currently in the research and validation phase.
The devices integrate paper-based electrochemical biosensors that allow for real-time, high-resolution monitoring of biochemical processes.
The project period is from 2024-03-01 to 2027-02-28.
The consortium is heavily research-oriented, consisting of 4 universities and 1 research organization, with a small industrial presence (1 SME, representing a 17% industry ratio). This structure indicates the project is currently focused on fundamental technical validation and proof-of-concept rather than immediate commercial rollout, though the inclusion of an SME provides a bridge to market application.
Contact the Università degli Studi di Roma Tor Vergata
Contact us to explore licensing opportunities for paper-based biosensors.
